Convergence CT, Inc. entered into a non-binding letter of intent to acquire VSAC for approximately $140 million in a reverse merger transaction in August 2024. The SPAC had pursued a business combination with Mediforum Co., Ltd., a Korean company, but the deal failed to close before the deadline expired.
Cyborg Score Rationale
VSAC failed to complete a business combination by its contractual deadline and entered liquidation in October 2024. The SPAC is no longer operating as a going concern.
Top Insights
(October 2024) Company announced delisting and liquidation after failing to meet business combination deadline
(October 2024) Sponsor Vision Sensing LLC did not deposit required extension fee to extend deadline from October 3 to November 3, 2024
(August 2024) Convergence CT entered into non-binding letter of intent to acquire VSAC for approximately $140 million
(January 2024) Company announced business combination with Mediforum Co., Ltd., but deal did not close
Recent Developments
(October 2024) Delisting and liquidation announced; public shareholders received $11.92 per share redemption
(August 2024) Convergence CT non-binding acquisition letter of intent announced